Future Clinical Research with Icodextrin-Containing Solutions

Mistry C.D. , Gokal E. , Mallick N.P. Glucose polymer as an osmotic agent in CAPD. In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich, 1986; 241–8.

Mistry C.D. , Mallick N.P. , Gokal R. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; 2: 178–82.

Winchester J.F. , Stegink L.D. , Gross A.M. Comparison of glucose polymer and dextrose as osmotic agents in CAPD. In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich, 1986; 231–40.

Higgins J.T. , Gross M.L. , Somani P. Patient tolerance and dialysis effectiveness of a glucose polymer-containing peritoneal dialysis solution. Perit Dial Bull, 1984; 4: S131–3.

Rubin J. , Klein E. , Jones Q. , Planch A. , Bower J. Evaluation of a polymer dialysate. Trans Am Soc Artif Intern Organs, 1983; 29: 62–5.

Mistry C.D. , Gokal R. , Peers E.M. , and the MIDAS study group. A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46: 496–503.

Gokal R. , Mistry C.D. , Peers E. , and the MIDAS study group: A United Kingdom multicenter study of icodextrin in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14(Suppl 2): S22–7.

Cooper A. , Henderson I.S. , Jones M.C. Daytime dwell with 7.5% icodextrin in automated peritoneal dialysis (APD). J EDTNA-ERCA 1995; 21(Suppl 1): 21.

Posthuma N. , ter Wee P.M. , Verbrugh H.A. , Oe P.L. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997; 12: 550–3.

Mistry C.D. , Gokal R. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: The role for ‘colloid’ osmosis. Clin Sci 1993; 85(4): 495–500.

Mistry C.D. , Bhowmick B. , Ashman R. , Uttley L. Clinical studies of new icodextrin formulations. Perit Dial Int 1994; 14(Suppl 2): S55–7.

Mistry C.D. , Gokal R. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) + 0.35% glucose solution: a 3-month study. Nephrol Dial Transplant 1993; 8: 443–7.

Faller B. , Shockley T. , Genestier S. A comparative clinical study of peritoneal dialysis solutions containing polyglucose and polyglucose in combination with amino acids. J Am Soc Nephrol 1995; 6(3): 510.

Peers E.M. , Scrimgeour A.C. , Haycox A.R. Cost-containment in CAPD patients with ultrafiltration failure. Clin Drug Invest 1995; 10: 53–8.

Wilkie M.E. , Plant M.J. , Edwards L. , Brown C.B. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of CAPD technique survival. Pert Dial Int 1997; 17: 84–6.

Peers E.M. , Scrimgeour A.C. Icodextrin can prolong technique survival in CAPD patients with ultrafiltration failure. J Am Soc Nephrol September 1995; 6(3): 513.

McArdle C.S. , Kerr D.J. , O'Gorman P. Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long term intraperitoneal treatment approach for advanced colorectal carcinoma. Br J Cancer 1994; 70: 762–6.

Millar D.J. , Dawnay A.B. Glycation of albumin with icodextrin. J Am Soc Nephrol 1995; 6(3): 551.

Millar D.J. , Dawnay A.B. Heat sterilization of PD fluid promotes advanced glycation end-product (AGE) formation. J Am Soc Nephrol 1995; 6(3): 551.

Ho-dac-Pannekeet M.M. , Schouten N. , Langendijk M. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979–86.

Ho-dac-Pannekeet M.M. , Imholz A.L.T. , Struijk D.G. The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48: 866–75.

Krediet R.T. , Struijk D.G. , Koomen D.G. , Arisz L. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 1991; 37: 662–7.

Shockley T.R. , Ofsthun N.J. Pathways for fluid loss from the peritoneal cavity. Blood Purif 1992; 10: 115–21.

Alsop R.M. History, chemical, and pharmaceutical development of icodextrin. Perit Dial Int 1994; 14(Suppl 2): S5–12.

Mistry C.D. , Gokal R. Icodextrin in peritoneal dialysis: early development and clinical use. Perit Dial Int 1994; 14(Suppl 2): S13–21.

Davies D.S. Kinetics of icodextrin. Perit Dial Int 1994; 14(Suppl 2): S45–50.

Rubin J. , Jones Q. , Planch A. , Bower J. , Klein E. Substitution of a starch polymer for glucose in peritoneal dialysis. Nephron 1985; 39: 40–6.

Rippe B. , Stelin G. , Ahlmen J. Lymph flow from the peritoneal cavity in CAPD patients. In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich, 1986; 24–30.

Mactier R.A. , Khanna R. Absorption of fluid and solutes from the peritoneal cavity: Theoretic and therapeutic implications and applications. ASAIO Trans 1989; 35: 122–31.

Wang T. , Heimbürger O. , Waniewski J. , Bergström J. , Lindholm B. Increased peritoneal permeability in CAPD results in decreased fluid and small solute removal, and lower survival. J Am Soc Nephrol 1996; 7: 1468.

Wang T. , Heimbürger O. , Chen C. , Bergström J. , Lindholm B. Fluid removal by polyglucose solution is not simple as we thought (Abstract). 14th ISN congress, Sydney, Australia, 1997.

Flessner M. , Schwab A. Pressure threshold for fluid loss from the peritoneal cavity. Am J Physiol 1996; 270: F377–90.

Gokal R. Osmotic agents in peritoneal dialysis. Contrib Nephrol 1990; 85: 126–33.

Hull A.R. It's time for a paradigm shift in nephrology. Neph News and Issues 1996; 10: 26–7.

Tattersall J. , Greenwood R. , Farrington K. Urea kinetics and when to commence dialysis. Am J Nephrol 1995; 15: 283–9.

Campbell J.D. , Ewingman B. , Hosokawa M. , Van Stone J.C. The timing of referral patients with end-stage renal disease. Dial Transplant 1989; 18: 660–8.

Hakim R.M. , Lazarus J.M. Initiation of dialysis. J Amer Soc Nephrol 1995; 6: 1319–28.

Jungers P. , Zingraff J. , Albouze G. Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 1993; 8: 1089–93.

Innes A. , Rowe P.A. , Burden R.P. , Morgan A.G. Early deaths on renal replacement therapy: The need for early nephrological referral. Nephrol Dial Transplant 1992; 7: 467–71.

Ratcliffe P.J. , Phillips R.E. , Oliver D.O. Late referral for maintenance dialysis. Br Med J 1984; 288: 441–3.

Khan I.H. , Catto G.R.D. , Edward N. , MacLeod A.M. Chronic renal failure: Factors influencing nephrology referral. Quart J Med 1994; 87: 559–64.

de Fijter C.W.H. , Verbrugh H.A. , Oe P.L. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21: 411–8.

Thomas S. , Schenk U. , Fischer F-P In Vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. Am J Kidney Dis 1997; 29: 246–53.